Constrained RNA polymerase mutational pathways distinguish corallopyronin A resistance from rifampicin resistance in staphylococci
Jesenko Karačić, Sabina Karačić, Miriam Grosse, Andrea Schiefer, Kenneth Pfarr, Tanja Schneider, Achim Hoerauf, Gabriele Bierbaum · 2026
Read Constrained RNA polymerase mutational pathways distinguish corallopyronin A resistance from rifampicin resistance in staphylococci by Jesenko Karačić, Sabina Karačić, Miriam Grosse, Andrea Schiefer, Kenneth Pfarr, Tanja Schneider, Achim Hoerauf, Gabriele Bierbaum (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13424638.txt.
Description
Karačić and co-authors map how staphylococci evolve resistance to a new antibiotic in this 2026 microbiology study. Corallopyronin A, a natural product, blocks bacterial RNA polymerase. That enzyme reads DNA into RNA. The new drug blocks it at another site than the older drug rifampicin. The team compared how readily resistance arises to each.
Across five staphylococcal strains, resistance mutations appeared less often for corallopyronin again and again. Rifampicin-to-corallopyronin ratios ran 2.3 to 2.7 in fluctuation tests. Sequencing 41 resistant mutants showed changes in just two polymerase subunits. The changes sat at a few hotspots. Rifampicin resistance spreads more widely by contrast. Corallopyronin resistance also cost the bacteria 12 to 15 percent of fitness in head-to-head growth contests. The authors argue the narrower escape routes make the new drug harder to beat.
Catalog record
| CREATOR | Jesenko Karačić, Sabina Karačić, Miriam Grosse, Andrea Schiefer, Kenneth Pfarr, Tanja Schneider, Achim Hoerauf, Gabriele Bierbaum |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |